[1]
S. S, “A Novel Sustained-Release In-Situ Implant of Fluvoxamine Ameliorates Depressive-Like Behaviours in a CUMS Mouse Model”, CTBP, vol. 20, no. 2, pp. 2882–2891, Apr. 2026.